Northwire Canada EditionTuesday, July 14, 2026
Northwire
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%
Production / Operations

Herbal Dispatch Announces Record-Breaking Month of $4.1M in Sales for October 2025

HERB · Price

Executive Summary

  • Herbal Dispatch reported record October 2025 gross sales of approximately $4.1 M, a 273 % increase versus the Q3 average.
  • The company raised its Q4 2025 sales outlook to $6.4 M–$7.0 M, implying up to a 112 % rise over Q3 2025 results.
  • Management highlighted continued domestic expansion, new product launches and strong e‑commerce traction as drivers of the upgraded guidance.

Key Details

  • October 2025 gross sales: ≈ $4.1 M (highest month ever).
  • Average monthly sales in Q3 2025: $1.1 M; October increase of 273 % versus that average.
  • Updated Q4 2025 sales forecast: $6.4 M–$7.0 M, representing up to a 112 % increase over Q3 2025’s $3.3 M.
  • Growth attributed to:
  • Robust demand in the recreational cannabis segment.
  • BC General Employees’ Union strike limiting wholesale shipments, shifting retailer purchases to independent wholesalers and direct‑delivery program.
  • Ongoing domestic expansion across Canada.
  • Strengthening international partnerships.
  • New product launches on herbaldispatch.com e‑commerce platform.
  • Company remains “well capitalized” for growth into 2026; expects gross margins consistent with recent quarters while pursuing operational efficiencies.
  • Full Q3 2025 financial results to be released in the coming weeks (SEDAR and company website).

Notable Quotes

“October's record sales underscore the strength of our craft cannabis portfolio and scalability of our business model,” said Philip Campbell, CEO and Director.
“As we progress through the final quarter of 2025, we are well‑positioned to capitalize on emerging opportunities in both domestic and export markets.”

Read the original news release →

More from Herbal Dispatch Inc.